Armata Pharmaceuticals In...

2.00
0.01 (0.74%)
At close: Mar 03, 2025, 3:59 PM
1.99
-0.50%
After-hours: Mar 03, 2025, 08:00 PM EST

Armata Pharmaceuticals Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99 FY98 FY97 FY96 FY95 FY94 FY93
Net Income -69.05M -36.92M -23.16M -22.18M -19.48M -12.11M -12.84M -18.84M -516K 23.11M -58.41M -4.26M -20.72M -16.13M -33.99M -19.2M -14.26M -14.83M -23.77M -27.17M -43.97M -26.7M -8.7M -14.2M -26M -9.9M -8.4M -5.1M
Depreciation & Amortization 972K 892K 1.17M 1.11M 1.35M 389K 374K 369K 330K 158K 82K 91K 516K 602K 720K 1.32M 1.29M 2.42M 3.62M 8.69M 3.46M 1.6M 1.6M 1.6M 1.9M 1.4M 1.3M 400K
Stock-Based Compensation 938K 3.1M 2.88M 3.48M 4.27M 478K 700K 2M 483K 1.94M 1.44M 9K 718K 966K n/a n/a n/a n/a n/a 80K n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital -9.69M -3.23M -3.41M -1.42M -815K 2K 381K 167K -429K 513K 233K 208K -865K 1.47M -508K n/a n/a n/a 816B -7.42M n/a n/a n/a n/a n/a n/a n/a n/a
Other Non-Cash Items 29.36M 171K 60K 628K 918K 1.84M 4.33M 5.77M -9.85M -37.22M 5.2M 31K -87K 966K 22.14M 124K -994K 822K 2.85M 3.67M 43.14M 15.8M 1.1M 100K 12.8M n/a -200K n/a
Deferred Income Tax n/a -171K -1.31M -432K -454K -328K -1.3M -556K -73K n/a 43.19M -1K 7.84M -650K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital -9.65M 439K -3.22M -874K -2.19M 345K -457K 670K -158K -556K 1.05M -151K 1.43M 361K -508K 1.36M -1.56M 361K -2.8M -8.81M -3.23M -1.3M 200K n/a 900K n/a 100K 300K
Operating Cash Flow -47.42M -32.48M -23.57M -18.27M -15.58M -9.38M -9.19M -10.59M -9.78M -12.57M -7.45M -4.28M -10.3M -13.88M -11.64M -16.39M -15.52M -11.23M -20.1M -23.54M -605.54K -10.6M -5.8M -12.5M -10.4M -8.5M -7.2M -4.4M
Capital Expenditures -8.14M -2.21M -1.3M -824K -131K -44K -58K -279K -210K -1.2M -102K -53K -738K -554K -81K -669K -408K -316K -563K -4.41M -2.8M -1.9M -200K -700K -1.5M -1.3M -900K -4.5M
Acquisitions n/a n/a n/a n/a 3.01M 65K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 358.89K n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a -3.39M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -500K -17.7M -800K -23.6M -13M -13M -8.8M
Sales Maturities Of Investments n/a n/a n/a n/a n/a 13.02M n/a n/a n/a n/a n/a n/a 16K 16K 49K 57K n/a n/a n/a n/a 3.02M 7.4M 11.7M 12.1M 20.4M n/a n/a n/a
Other Investing Acitivies 10K n/a n/a n/a 3.01M 9.69M -1.91M n/a n/a n/a 204K 3.15M 60K 24K n/a n/a n/a n/a -1.93M -2.81M -2.81M 100K n/a n/a 1.4M 10M 9.2M 13.8M
Investing Cash Flow -8.13M -2.21M -1.3M -824K 2.88M -44K -58K -279K -210K -1.2M -102K 3.1M -662K -514K -32K -612K -408K -316K -2.49M -7.22M -2.22M 5.1M -6.2M 10.6M -3.3M -4.3M -4.7M 500K
Debt Repayment 54.03M n/a n/a 717K n/a n/a -815K -100K n/a n/a 2M 950K -259K -1.36M -1.15M -3M -820K -1.03M 5.24M 14.26M 37.36M -300K -1.1M -800K 100K -700K 1.6M 800K
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a -80K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -945K n/a -400K n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -38K -375K -801K -400K -1M 203K 133K -160K 396K n/a 7M n/a n/a n/a n/a n/a n/a n/a 750K n/a n/a 1.2M -100K n/a -100K n/a n/a n/a
Financial Cash Flow 53.99M 44.02M 25.52M 23.21M 8.97M 12.45M 8.67M 7.21M 12.78M n/a 27M 950K -259K 24.63M 3.75M -2.97M 28.97M 20M 10.01M 17.32M 37.36M 7.8M 12.9M -500K 15M 12.7M 13.1M 800K
Net Cash Flow -1.57M 9.32M 639K 4.12M -3.73M 3.02M -579K -3.66M 2.79M -13.77M 19.49M -234K -11.23M 10.24M -7.92M -19.97M 13.04M 8.45M -12.58M -13.44M 34.53M 2.2M -1M -2.5M -2.2M -2.3M -1.2M -4.2M
Free Cash Flow -55.57M -34.69M -24.88M -19.09M -15.71M -9.43M -9.25M -10.87M -9.99M -13.77M -7.55M -4.33M -11.04M -14.44M -11.72M -17.06M -15.93M -11.55M -20.66M -27.95M -3.4M -12.5M -6M -13.2M -11.9M -9.8M -8.1M -8.9M